Just What You Want, But Fake | GenomeWeb

Two inspections by the US Food and Drug Administration, an internal company investigation, and an inspection by a third party found instances of misconduct and other violations at a Cetero Research facility in Houston, reports Reuters. "The pattern of misconduct was serious enough to raise concerns about the integrity of the data Cetero generated during the five-year time frame," FDA said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.